Inhibrx Stock Options Expiring on 20th of December

INBX Stock  USD 15.26  0.37  2.37%   
Inhibrx's latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 0.54 with a put-to-call open interest ratio of 0.84 over 17 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2024-12-20. The total put volume is at 296, with calls trading at the volume of 296. This yields a 0.36 put-to-call volume ratio.

Open Interest Against 2024-12-20 Option Contracts

Inhibrx option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Inhibrx's lending market. For example, when Inhibrx's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Inhibrx, he or she must hedge the risk by shorting Inhibrx stock over its option's life.
The chart above shows Inhibrx's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Inhibrx's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Inhibrx's option, there is no secondary market available for investors to trade.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Inhibrx In The Money Call Balance

When Inhibrx's strike price is surpassing the current stock price, the option contract against Inhibrx stock is said to be in the money. When it comes to buying Inhibrx's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Inhibrx are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Inhibrx Current Options Market Mood

Inhibrx's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Inhibrx Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Inhibrx's options investors are not very successful. Inhibrx's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Inhibrx contract

Base on the Rule 16, the options market is currently suggesting that Inhibrx will have an average daily up or down price movement of about 0.0338% per day over the life of the 2024-12-20 option contract. With Inhibrx trading at USD 15.26, that is roughly USD 0.00515. If you think that the market is fully incorporating Inhibrx's daily price movement you should consider buying Inhibrx options at the current volatility level of 0.54%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Inhibrx Option Chain

When Inhibrx's strike price is surpassing the current stock price, the option contract against Inhibrx stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Inhibrx's option chain is a display of a range of information that helps investors for ways to trade options on Inhibrx. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Inhibrx. It also shows strike prices and maturity days for a Inhibrx against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntExpirationCurrent SpreadLast Price
Call
INBX Option Call 20-12-2024 1502024-12-200.0 - 0.01.1In
Call
INBX Option Call 20-12-2024 1702024-12-200.0 - 0.00.35Out
Call
INBX Option Call 20-12-2024 2282024-12-200.0 - 0.011.6Out
Call
INBX Option Call 20-12-2024 2582024-12-200.0 - 0.09.2Out
Call
INBX Option Call 20-12-2024 30672024-12-200.0 - 0.04.2Out
Call
INBX Option Call 20-12-2024 3526522024-12-200.0 - 0.00.5Out
Call
INBX Option Call 20-12-2024 407452024-12-200.0 - 0.00.05Out
Call
INBX Option Call 20-12-2024 4512024-12-200.0 - 0.00.75Out
Call
INBX Option Call 20-12-2024 5012024-12-200.0 - 5.00.75Out
Call
INBX Option Call 20-12-2024 5552024-12-200.0 - 0.00.01Out
 Put
INBX Option Put 20-12-2024 1202024-12-200.0 - 0.00.45Out
 Put
INBX Option Put 20-12-2024 1502024-12-200.0 - 0.01.15Out
 Put
INBX Option Put 20-12-2024 25112024-12-200.0 - 0.00.05In
 Put
INBX Option Put 20-12-2024 3023192024-12-200.0 - 0.00.05In
 Put
INBX Option Put 20-12-2024 354502024-12-200.0 - 0.02.0In
 Put
INBX Option Put 20-12-2024 401552024-12-200.0 - 0.07.0In
 Put
INBX Option Put 20-12-2024 4512024-12-200.0 - 0.010.4In

Inhibrx Total Stockholder Equity

Total Stockholder Equity

45.68 Million

At this time, Inhibrx's Total Stockholder Equity is fairly stable compared to the past year.

Inhibrx Corporate Management

Leah JDCorporate VPProfile
Mark LappeChairman, FounderProfile
Charbel PharmDVice PlanningProfile
BS CPAChief OfficerProfile
Jeffrey JensenExecutive OfficerProfile
Brendan EckelmanExecutive OfficerProfile
Carlos BaisExecutive SciencesProfile

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.